JESUS MANUEL
MERAYO LLOVES
Catedrático de Universidad
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (27)
2024
-
Validación Rasch del Keratoconus End-Points Assessment Questionnaire en población española con queratocono
Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 8, pp. 323-330
2022
-
Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus
Expert Opinion on Biological Therapy, Vol. 22, Núm. 1, pp. 31-45
2021
-
Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technology
Experimental Eye Research, Vol. 203
-
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
Cornea, Vol. 40, Núm. 1, pp. 107-112
-
Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases
International Ophthalmology, Vol. 41, Núm. 7, pp. 2347-2358
2020
-
Antioxidant role of PRGF on RPE cells after blue light insult as a therapy for neurodegenerative diseases
International Journal of Molecular Sciences, Vol. 21, Núm. 3
-
Development and optimization of freeze-dried eye drops derived from plasma rich in growth factors technology
Translational Vision Science and Technology, Vol. 9, Núm. 7, pp. 1-16
-
Plasma rich in growth factors enhances cell survival after in situ retinal degeneration
International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-16
-
Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases
European Journal of Ophthalmology, Vol. 30, Núm. 1, pp. 94-103
-
Plasma rich in growth factors reduces blue light-induced oxidative damage on retinal pigment epithelial cells and restores their homeostasis by modulating vascular endothelial growth factor and pigment epithelium-derived factor expression
Clinical and Experimental Ophthalmology, Vol. 48, Núm. 6, pp. 830-838
-
Potential Effect of Plasma Rich in Growth Factors-Endoret in Stromal Wound Healing in Additive Surgery
Ophthalmic Research, Vol. 63, Núm. 2, pp. 203-212
2018
-
Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)
PLoS ONE, Vol. 13, Núm. 10
-
PRGF in equine corneal cells: A standardised protocol is the key to achieve accurate results
Equine Veterinary Journal
-
Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
International Medical Case Reports Journal, Vol. 11, pp. 97-103
-
Plasma rich in growth factors for the treatment of dry eye after LASIK surgery
Ophthalmic Research, Vol. 60, Núm. 2, pp. 80-86
-
Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders
Medicine (United States), Vol. 97, Núm. 17
-
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops
International Ophthalmology, Vol. 38, Núm. 3, pp. 1193-1204
2017
-
Allogeneic blood-based therapies: Hype or hope?
Eye (Basingstoke)
-
Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology
Ocular Surface, Vol. 15, Núm. 2, pp. 248-256
-
Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation
Scientific Reports, Vol. 7, Núm. 1